Precision BioSciences (DTIL) Earnings Date & Reports

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DTIL is expected to report earnings to fall 40.48% to -75 cents per share on November 10

Precision BioSciences DTIL Stock Earnings Reports

Q3'26

Est.

$-0.75

Q2'26

Missed

by $0.50

Q1'26

Missed

by $0.57

Q4'25

Beat

by $1.69

Q3'25

Missed

by $1.03

The last earnings report on August 06 showed earnings per share of -125 cents, missing the estimate of -75 cents. With 139.04K shares outstanding, the current market capitalization sits at 244.27M.

View a ticker or compare two or three

DTIL

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days